Nanostring NCOUNTER Canine Io Panel - 12 Assays NSTG115000456

NanoString Technologies - nCounter® Canine IO Panel
Full 800-plex: 780 canine immune response genes + 20 reference genes.

Covering hundreds of genes involved in the immune response of canines to immuno-oncology therapeutics and designed with experts in canine comparative oncology, the nCounter Canine IO Panel is the only gene expression panel built to study the tumor and immune response to IO treatments in dogs.
The panel takes advantage of tumor-specific coverage for the most common canine cancers to enable researchers to share data and access enhanced statistical power, potentially improving clinical trial success by translating findings from the treatment of spontaneous canine cancer to humans.

• Profile 800 genes across 47 annotated pathways involved in canine immune response to IO treatments
• Overlapping content with NanoString’s Human PanCancer IO 360 and PanCancer Immune Profiling Panels provides a suite of panels for comparative studies
• PanCancer coverage with tumor specific content for top canine cancers including Melanoma, Osteosarcoma, Lymphoma, Urothelial Carcinoma, and Glioblastoma
• Easy to use nCounter system provides data in 24 hours with less than 30 minutes hands on time and simple data analysis
• Easy data sharing and collaboration with a common set of genes and a panel standard